Cognitive decline is common in older adults, even in the absence of significant medical or neurological conditions. Recent work implicates serum levels of brain-derived neurotrophic factor in age-related cognitive decline, though no study has directly examined this possibility. A total of 35 older adults without neurological history underwent fasting blood draw and completed a brief neuropsychological test battery during a single session. After adjusting for demographic and medical confounds, higher serum brain-derived neurotrophic factor levels were associated with better performance on the Mini-Mental State Examination (r = .36) and short form of the Boston Naming Test (r = .39). These findings extend work from Alzheimer disease and vascular dementia samples and indicate that higher brain-derived neurotrophic factor levels are associated with better neuropsychological function in healthy older adults. The exact mechanisms for this relationship are unknown and require further examination.
Ritchie K., Ledesert B., Touchon J.Subclinical cognitive impairment: epidemiology and clinical characteristics . Compr Psychiatry. 2000;41:61-65.
2.
Cargin JR, Maruff P., Collie A., Masters C.Mild memory impairment in healthy older adults is distinct from normal aging . Brain Cogn. 2006;60:146-155.
3.
De Jager C., Blackwell AD, Budge MM, Sahakian BJPredicting cognitive decline in healthy older adults. Am J Geriatr Psychiatry. 2005;13:735-740.
4.
Chapman DP, Williams SM, Strine TW, Anda RF, Moore MJDementia and its implications for public health [serial online]. Prev Chronic Dis.2006. http://www.cdc.gov/pcd/issues/2006/apr/05_0167.htm . Accessed March 18, 2007.
5.
Bartzokis G.Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging. 2004;25:5-18.
6.
Blank T., Nijholt I., Spiess J.Treatment strategies of age-related memory dysfunction by modulation of neuronal plasticity. Mini Rev Med Chem. 2007;7:55-64.
7.
Pfefferbaum A., Adalsteinsson E., Sullivan EVFrontal circuitry degradation marks healthy adult aging: evidence from diffusion tensor imaging. Neuroimage . 2005;26: 891-899.
8.
Huang EJ, Reichardt LFNeurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677-736.
9.
Egan M., Kojima M., Callilcott J., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003;112:257-269.
10.
Gorski J., Balogh S., Wehner J., Jones K.Learning deficits in forebrain-restricted brain derived-neurotrophic factor mutant mice. Neurosci. 2003;121:341-354.
11.
Harris S., Fox H., Wright A., et al. The brain-derived neurotrophic factor Val66Met polymorphism is associated with age-related change in reasoning skills. Mol Psychiatry. 2006;11:505-513.
12.
Monteggia LM , Barrot M., Powell CM, et al. Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci U S A. 2004;101: 10827-10832.
13.
Laske C., Stransky E., Leyhe T., et al. Stage-dependent BDNF serum concentrations in Alzheimer's disease . J Neural Transm. 2006;113:1217-1224.
14.
Peng S., Wuu J., Mufson E., Fahnestock M.Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem. 2005;93:1412-1421.
15.
Yasutake C., Kuroda K., Yanagawa T., et al. Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia. Eur Arch Psychiatry Clin Neurosci. 2006; 256:402-406.
Lacritz LH, Cullum CMThe Hopkins verbal learning test and the CVLT: a preliminary comparison. Arch Clin Neuropsychol. 1998;13:623-628.
18.
Shapiro AM, Benedict RH, Schretlen D., Brandt J.Construct and concurrent validity of the Hopkins verbal learning test-revised. Clin Neuropsychol. 1999;13:348-358.
19.
Reitan R.Validity of the trail making test as an indicator of organic brain damage . Percept Mot Skills. 1958;8: 271-276.
20.
Wechsler D.Manual for the Wechsler Adult Intelligence Scale. San Antonio, TX: The psychological corporation; 1997.
21.
DuBois B., Slachevsky A., Litvan I., Pillon B.The FAB: a frontal assessment battery at bedside . Neurology. 2000;55:1621-1626.
22.
Kaplan E., Goodglass H., Weintraub S., et al. Boston Naming Test. Philadelphia, PA: Lea & Febiger; 1983.
23.
Eslinger P., Damasio A., Benton A.The Iowa Screening Battery for Mental Decline. Iowa City, IA: University of Iowa; 1984.
24.
Glasgow RE, Ory MG, Klesges LM, Cifuentes M., Fernald DH, Green LAPractical and relevant self-report measures of patient health behaviors for primary care research. Ann Fam Med. 2005;3:73-81.
25.
University of Washington Health Promotion Reseach Center.Rapid assessment of physical activity (RAPA). http://hmcrc.srph.tau.edu. Accessed March 1, 2007.
26.
Elliott E., Ginzburg I.The role of neurotrophins and insulin on tau pathology in Alzheimer's disease . Rev Neurosci. 2006;17:635-642.
27.
Kuipers SD, Bramham CRBrain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy. Curr Opin Drug Discov Devel. 2006;9:580-586.
28.
Blasko I., Grubeck-Loebenstein B.Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease. Drugs Aging. 2003;20:101-113.
29.
Kimura N., Takahashi M., Tashiro T., Terao K.Amyloid beta up-regulates brain-derived neurotrophic factor production from astrocytes: rescue from amyloid beta-related neuritic degeneration. J Neurosci Res. 2006;84: 782-789.
30.
Lindvall O. , Ernfors P., Bengzon J., et al. Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Proc Natl Acad Sci U S A. 1992;89:648-652.
31.
Tong L., Balazs R., Thornton PL, Cotman CWBeta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons. J Neurosci. 2004;24:6799-6809.
32.
Tsai SJStatins may enhance the proteolytic cleavage of proBDNF: implications for the treatment of depression [published online ahead of print]. Med Hypotheses. 2007;68:1296-1299.
33.
Manni L., Nikolova V., Vyagova D., et al. Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes. Int J Cardiol. 2005;102:169-171.
34.
Bueller JA, Aftab M., Sen S., et al. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry.2006;59:812-815.
35.
Nemoto K., Ohnishi T., Mori T., et al. The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neurosci Lett. 2006;397:25-29.
36.
Colcombe SJ , Kramer AF, McAuley E., et al. Neurocognitive aging and cardiovascular fitness: recent findings and future directions. J Mol Neurosci . 2004;24:9-14.
37.
Winter B., Breitenstein C., Mooren FC, et al. High impact running improves learning [published online ahead of print]. Neurobiol Learn Mem. 2007;87:597-609.
